Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322712
Status:
TERMINATED
Last Update Posted:
2024-02-05
First Post:
2006-05-05
Brief Title:
INST 0603C Patients With UnresectableMetastatic Pancreatic Cancer Treated in the UNM Cancer
Sponsor:
University of New Mexico
Organization:
University of New Mexico
Study Overview
Official Title:
INST 0603C Chart Review on Patients With UnresectableMetastatic Pancreatic Cancer Treated in the UNM Cancer
Status:
TERMINATED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This is only a chart review This is not a clinical trial and was inadvertently entered in the system
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chart Review of patients with pancreatic cancer treated with combination of irinotecan oxaliplatin and cetuximab
Detailed Description:
Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with combination of irinotecan oxaliplatin and cetuximab
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None